Cargando…
Epigenetic identification of mitogen-activated protein kinase 10 as a functional tumor suppressor and clinical significance for hepatocellular carcinoma
BACKGROUND: Mitogen-activated protein kinase 10 (Mapk10) is a member of the c-jun N-terminal kinases (jnk) subgroup in the MAPK superfamily, and was proposed as a tumor suppressor inactivated epigenetically. Its role in hepatocellular carcinoma (HCC) has not yet been illustrated. We aimed to investi...
Autores principales: | Tang, Liping, Zhu, Shasha, Peng, Weiyan, Yin, Xuedong, Tan, Cui, Yang, Yaying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863782/ https://www.ncbi.nlm.nih.gov/pubmed/33604188 http://dx.doi.org/10.7717/peerj.10810 |
Ejemplares similares
-
Coordinative control of G2/M phase of the cell cycle by non-coding RNAs in hepatocellular carcinoma
por: Shi, Jun, et al.
Publicado: (2018) -
Sorting nexin-1 is a candidate tumor suppressor and potential prognostic marker in gastric cancer
por: Zhan, Xiao-Yong, et al.
Publicado: (2018) -
Trends in hepatocellular carcinoma research from 2008 to 2017: a bibliometric analysis
por: Miao, Yan, et al.
Publicado: (2018) -
A decision tree model to predict liver cirrhosis in hepatocellular carcinoma patients: a retrospective study
por: Zhou, Zheyu, et al.
Publicado: (2023) -
Identification of an eight-gene signature for survival prediction for patients with hepatocellular carcinoma based on integrated bioinformatics analysis
por: Qiao, Guo-jie, et al.
Publicado: (2019)